id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT03112863
|
41:55:treatment,57:76:treatment,80:99:treatment,
|
Those who have used products containing salicylic acid, beta hydroxyl acids or vitamins A, C, or E in the last 14 days
| 3
|
[
"Those",
"who",
"have",
"used",
"products",
"containing",
"salicylic",
"acid",
",",
"beta",
"hydroxyl",
"acids",
"or",
"vitamins",
"A",
",",
"C",
",",
"or",
"E",
"in",
"the",
"last",
"14",
"days"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02131805
|
1:8:cancer,
|
BCC/SCC within 3 cm of another treated or untreated BCC/SCC
| 3
|
[
"BCC/SCC",
"within",
"3",
"cm",
"of",
"another",
"treated",
"or",
"untreated",
"BCC/SCC"
] |
[
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02329652
|
7:30:chronic_disease
|
Other neurological conditions
| 3
|
[
"Other",
"neurological",
"conditions"
] |
[
0,
2,
2
] |
NCT02219581
|
90:130:treatment
|
Any contraindication that would prevent the patient from being treated with the standard multimodal postoperative pain management regimen History of infection of surgical knee
| 3
|
[
"Any",
"contraindication",
"that",
"would",
"prevent",
"the",
"patient",
"from",
"being",
"treated",
"with",
"the",
"standard",
"multimodal",
"postoperative",
"pain",
"management",
"regimen",
"History",
"of",
"infection",
"of",
"surgical",
"knee"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03175978
|
1:28:treatment,30:43:treatment,48:66:treatment,68:85:treatment,93:100:treatment
|
Prior systemic chemotherapy, immunotherapy, or biological therapy, radiation therapy and/or surgery are allowed
| 3
|
[
"Prior",
"systemic",
"chemotherapy",
",",
"immunotherapy",
",",
"or",
"biological",
"therapy",
",",
"radiation",
"therapy",
"and/or",
"surgery",
"are",
"allowed"
] |
[
1,
1,
1,
0,
1,
0,
0,
1,
1,
0,
1,
1,
0,
1,
0,
0
] |
NCT01434472
|
49:58:treatment,,98:107:chronic_disease,118:152:chronic_disease
|
Patients must have an expected survival without treatment of > 60 days and must be free of major infection including human immunodeficiency virus (HIV)
| 3
|
[
"Patients",
"must",
"have",
"an",
"expected",
"survival",
"without",
"treatment",
"of",
">",
"60",
"days",
"and",
"must",
"be",
"free",
"of",
"major",
"infection",
"including",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
0,
0
] |
NCT03068780
|
1:17:chronic_disease,,
|
Kindler syndrome aged ≥21 days
| 3
|
[
"Kindler",
"syndrome",
"aged",
"≥21",
"days"
] |
[
2,
2,
0,
0,
0
] |
NCT01061515
|
48:73:cancer,86:96:cancer,100:126:cancer
|
Patients must have a histologically documented peritoneal carcinomatosis from either colorectal or appendiceal adenocarcinoma
| 3
|
[
"Patients",
"must",
"have",
"a",
"histologically",
"documented",
"peritoneal",
"carcinomatosis",
"from",
"either",
"colorectal",
"or",
"appendiceal",
"adenocarcinoma"
] |
[
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
3,
0,
3,
3
] |
NCT02413047
|
15:38:treatment,
|
Receiving any immunomodulator therapy within the past 3 months
| 3
|
[
"Receiving",
"any",
"immunomodulator",
"therapy",
"within",
"the",
"past",
"3",
"months"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT01896999
|
24:44:chronic_disease,62:79:treatment,101:148:treatment,159:186:treatment,199:212:treatment,220:230:treatment,232:245:treatment
|
Patients must not have autoimmune disorders or conditions of immunosuppression that require current ongoing treatment with systemic corticosteroids (or other systemic immunosuppressants), including oral steroids (i.e., prednisone, dexamethasone)
| 3
|
[
"Patients",
"must",
"not",
"have",
"autoimmune",
"disorders",
"or",
"conditions",
"of",
"immunosuppression",
"that",
"require",
"current",
"ongoing",
"treatment",
"with",
"systemic",
"corticosteroids",
"(",
"or",
"other",
"systemic",
"immunosuppressants",
")",
",",
"including",
"oral",
"steroids",
"(",
"i.e.",
",",
"prednisone",
",",
"dexamethasone",
")"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
1,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1,
0
] |
NCT02863809
|
1:36:chronic_disease,
|
Corneal or ocular surface infection within 30 days prior to study entry
| 3
|
[
"Corneal",
"or",
"ocular",
"surface",
"infection",
"within",
"30",
"days",
"prior",
"to",
"study",
"entry"
] |
[
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02797795
|
1:14:treatment,
|
Major surgery within 28 days before the first NEV801 dose
| 3
|
[
"Major",
"surgery",
"within",
"28",
"days",
"before",
"the",
"first",
"NEV801",
"dose"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03041441
|
20:44:chronic_disease
|
Known diagnosis of intracranial hypotension
| 3
|
[
"Known",
"diagnosis",
"of",
"intracranial",
"hypotension"
] |
[
0,
0,
0,
2,
2
] |
NCT03058679
|
,84:94:treatment
|
Patients may continue these medications at stable dose for the first six weeks and budesonide may be used at any dose
| 3
|
[
"Patients",
"may",
"continue",
"these",
"medications",
"at",
"stable",
"dose",
"for",
"the",
"first",
"six",
"weeks",
"and",
"budesonide",
"may",
"be",
"used",
"at",
"any",
"dose"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02560623
|
13:33:treatment,44:52:treatment,54:62:treatment
|
Patients on oral anticoagulation including Coumadin, Warfarin
| 3
|
[
"Patients",
"on",
"oral",
"anticoagulation",
"including",
"Coumadin",
",",
"Warfarin"
] |
[
0,
0,
1,
1,
0,
1,
0,
1
] |
NCT02048722
|
1:55:treatment,63:71:treatment,81:89:treatment,94:105:treatment
|
Therapeutic anticoagulation with Vitamin-K antagonists (e.g., warfarin) or with heparins and heparinoids
| 3
|
[
"Therapeutic",
"anticoagulation",
"with",
"Vitamin-K",
"antagonists",
"(",
"e.g.",
",",
"warfarin",
")",
"or",
"with",
"heparins",
"and",
"heparinoids"
] |
[
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0,
1,
0,
1
] |
NCT02293096
|
1:49:chronic_disease
|
severe peripheral arterial circulatory disorders
| 3
|
[
"severe",
"peripheral",
"arterial",
"circulatory",
"disorders"
] |
[
2,
2,
2,
2,
2
] |
NCT02479906
|
71:92:chronic_disease,102:120:chronic_disease,122:148:chronic_disease,150:153:chronic_disease
|
Subject diagnosed according to the SCID I as suffering from any other major Axis I disorder, such as Psychotic Disorder, Bipolar affective disorder, OCD
| 3
|
[
"Subject",
"diagnosed",
"according",
"to",
"the",
"SCID",
"I",
"as",
"suffering",
"from",
"any",
"other",
"major",
"Axis",
"I",
"disorder",
",",
"such",
"as",
"Psychotic",
"Disorder",
",",
"Bipolar",
"affective",
"disorder",
",",
"OCD"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
2
] |
NCT02264236
|
48:62:cancer,74:113:cancer,140:172:cancer,176:200:cancer,204:233:cancer
|
Subjects with prior history at any time of any in situ cancer, including lobular carcinoma of the breast in situ, cervical cancer in situ, atypical melanocytic hyperplasia or Clark I melanoma in situ or basal or squamous skin cancer are eligible, provided they are disease-free at the time of registration
| 3
|
[
"Subjects",
"with",
"prior",
"history",
"at",
"any",
"time",
"of",
"any",
"in",
"situ",
"cancer",
",",
"including",
"lobular",
"carcinoma",
"of",
"the",
"breast",
"in",
"situ",
",",
"cervical",
"cancer",
"in",
"situ",
",",
"atypical",
"melanocytic",
"hyperplasia",
"or",
"Clark",
"I",
"melanoma",
"in",
"situ",
"or",
"basal",
"or",
"squamous",
"skin",
"cancer",
"are",
"eligible",
",",
"provided",
"they",
"are",
"disease-free",
"at",
"the",
"time",
"of",
"registration"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02058095
|
30:48:chronic_disease
|
Infiltrative or inflammatory myocardial disease (amyloid, sarcoid)
| 3
|
[
"Infiltrative",
"or",
"inflammatory",
"myocardial",
"disease",
"(",
"amyloid",
",",
"sarcoid",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02531880
|
1:8:chronic_disease
|
Seizure focus localization will be determined by standard clinical, neurophysiologic, and imaging studies. Prior or concurrent enrollment in 18-N-0066 is required
| 3
|
[
"Seizure",
"focus",
"localization",
"will",
"be",
"determined",
"by",
"standard",
"clinical",
",",
"neurophysiologic",
",",
"and",
"imaging",
"studies",
".",
"Prior",
"or",
"concurrent",
"enrollment",
"in",
"18-N-0066",
"is",
"required"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02953509
|
1:46:treatment
|
autologous hematopoietic cell transplantation
| 3
|
[
"autologous",
"hematopoietic",
"cell",
"transplantation"
] |
[
1,
1,
1,
1
] |
NCT02520791
|
1:20:cancer,,
|
Follicular lymphoma grade 1, 2 or 3A that meets the following criteria
| 3
|
[
"Follicular",
"lymphoma",
"grade",
"1",
",",
"2",
"or",
"3A",
"that",
"meets",
"the",
"following",
"criteria"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01415752
|
35:57:treatment
|
Must be willing to take effective antiretroviral therapy if indicated
| 3
|
[
"Must",
"be",
"willing",
"to",
"take",
"effective",
"antiretroviral",
"therapy",
"if",
"indicated"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT00432094
|
,,30:41:treatment,,,,
|
Hemoglobin > 8 gm/dL without transfusion and off erythropoietin for 14 days or Aranesp for 21 days
| 3
|
[
"Hemoglobin",
">",
"8",
"gm/dL",
"without",
"transfusion",
"and",
"off",
"erythropoietin",
"for",
"14",
"days",
"or",
"Aranesp",
"for",
"21",
"days"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01842399
|
1:13:treatment
|
Barbiturates
| 3
|
[
"Barbiturates"
] |
[
1
] |
NCT02536794
|
1:23:treatment
|
bilateral oophorectomy
| 3
|
[
"bilateral",
"oophorectomy"
] |
[
1,
1
] |
NCT01876511
|
55:100:treatment,102:159:treatment,161:175:treatment,
|
received growth factors, including but not limited to granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage-colony stimulating factor (GM-CSF), erythropoietin, etc. within 2 weeks of study drug administration
| 3
|
[
"received",
"growth",
"factors",
",",
"including",
"but",
"not",
"limited",
"to",
"granulocyte-colony",
"stimulating",
"factor",
"(",
"G-CSF",
")",
",",
"granulocyte",
"macrophage-colony",
"stimulating",
"factor",
"(",
"GM-CSF",
")",
",",
"erythropoietin",
",",
"etc",
".",
"within",
"2",
"weeks",
"of",
"study",
"drug",
"administration"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02236013
|
26:69:chronic_disease
|
Subject has disseminated intravascular coagulation abnormality (DIC)
| 3
|
[
"Subject",
"has",
"disseminated",
"intravascular",
"coagulation",
"abnormality",
"(",
"DIC",
")"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02366819
|
20:27:chronic_disease,31:52:chronic_disease,168:177:treatment
|
Serious underlying medical or psychiatric illnesses that would, in the opinion of the treating physician, substantially increase the risk for complications related to treatment
| 3
|
[
"Serious",
"underlying",
"medical",
"or",
"psychiatric",
"illnesses",
"that",
"would",
",",
"in",
"the",
"opinion",
"of",
"the",
"treating",
"physician",
",",
"substantially",
"increase",
"the",
"risk",
"for",
"complications",
"related",
"to",
"treatment"
] |
[
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01959204
|
13:33:treatment,
|
Received an investigational drug within 28 days of dosing
| 3
|
[
"Received",
"an",
"investigational",
"drug",
"within",
"28",
"days",
"of",
"dosing"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT01964261
|
1:30:treatment
|
Implanted hydrocephalus shunt
| 3
|
[
"Implanted",
"hydrocephalus",
"shunt"
] |
[
1,
1,
1
] |
NCT02762825
|
1:20:chronic_disease
|
Atrial fibrillation
| 3
|
[
"Atrial",
"fibrillation"
] |
[
2,
2
] |
NCT02501733
|
38:54:chronic_disease
|
Patients with an active or suspected latent infection in or about the knee joint
| 3
|
[
"Patients",
"with",
"an",
"active",
"or",
"suspected",
"latent",
"infection",
"in",
"or",
"about",
"the",
"knee",
"joint"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02489422
|
55:78:chronic_disease,92:96:treatment,99:121:chronic_disease,123:136:chronic_disease,,166:187:chronic_disease
|
Has a self-reported history of diagnosed uncontrolled obstructive sleep apnea (ok if using CPAP), sleep-related seizures, sleep walking more than one time per week, restless leg syndrome, or a job with night shifts
| 3
|
[
"Has",
"a",
"self-reported",
"history",
"of",
"diagnosed",
"uncontrolled",
"obstructive",
"sleep",
"apnea",
"(",
"ok",
"if",
"using",
"CPAP",
")",
",",
"sleep-related",
"seizures",
",",
"sleep",
"walking",
"more",
"than",
"one",
"time",
"per",
"week",
",",
"restless",
"leg",
"syndrome",
",",
"or",
"a",
"job",
"with",
"night",
"shifts"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
1,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01953263
|
38:59:chronic_disease
|
Patients with significant (>grade 2) pelvic organ prolapse
| 3
|
[
"Patients",
"with",
"significant",
"(",
">",
"grade",
"2",
")",
"pelvic",
"organ",
"prolapse"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02152956
|
,,86:96:treatment
|
Requirement, at the time of study entry, for concurrent steroids > 10 mg/day of oral prednisone or the equivalent
| 3
|
[
"Requirement",
",",
"at",
"the",
"time",
"of",
"study",
"entry",
",",
"for",
"concurrent",
"steroids",
">",
"10",
"mg/day",
"of",
"oral",
"prednisone",
"or",
"the",
"equivalent"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01595529
|
1:11:treatment
|
suprapubic
| 3
|
[
"suprapubic"
] |
[
1
] |
NCT01407809
|
10:30:chronic_disease,,168:205:treatment,266:286:treatment,
|
Moderate visual function loss, defined as grade 3 on the Humphrey Visual Field Analyzer SITA Standard 24-2 Test grading scale (Table 4) at presentation and failure of treatment with acetazolamide (Diamox) given at efficient dose (2g/d or maximum tolerated dose) or Topiramate (Topamax) given at efficient dose (maximum 150mg daily)
| 3
|
[
"Moderate",
"visual",
"function",
"loss",
",",
"defined",
"as",
"grade",
"3",
"on",
"the",
"Humphrey",
"Visual",
"Field",
"Analyzer",
"SITA",
"Standard",
"24-2",
"Test",
"grading",
"scale",
"(",
"Table",
"4",
")",
"at",
"presentation",
"and",
"failure",
"of",
"treatment",
"with",
"acetazolamide",
"(",
"Diamox",
")",
"given",
"at",
"efficient",
"dose",
"(",
"2g/d",
"or",
"maximum",
"tolerated",
"dose",
")",
"or",
"Topiramate",
"(",
"Topamax",
")",
"given",
"at",
"efficient",
"dose",
"(",
"maximum",
"150mg",
"daily",
")"
] |
[
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03085485
|
1:28:treatment,
|
Revascularization procedure in the last year prior to screening
| 3
|
[
"Revascularization",
"procedure",
"in",
"the",
"last",
"year",
"prior",
"to",
"screening"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02152995
|
62:79:cancer
|
Patients must have histologically or cytologically confirmed thyroid carcinoma of follicular origin (including papillary, follicular, or poorly differentiated subtypes and their respective variants); confirmation of thyroid carcinoma will be done at Memorial Sloan-Kettering (MSK)
| 3
|
[
"Patients",
"must",
"have",
"histologically",
"or",
"cytologically",
"confirmed",
"thyroid",
"carcinoma",
"of",
"follicular",
"origin",
"(",
"including",
"papillary",
",",
"follicular",
",",
"or",
"poorly",
"differentiated",
"subtypes",
"and",
"their",
"respective",
"variants",
")",
";",
"confirmation",
"of",
"thyroid",
"carcinoma",
"will",
"be",
"done",
"at",
"Memorial",
"Sloan-Kettering",
"(",
"MSK",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02474368
|
62:106:cancer,108:129:cancer,131:152:cancer,157:171:cancer,255:271:cancer
|
Pathologically proven recurrent disease or a second primary (squamous cell carcinoma of the head and neck, nasopharyngeal cancer, salivary gland cancer, or thyroid cancer) within the head and neck region, deemed to be unresectable or resected with gross residual disease remaining (determined by either operative/pathology report or post-surgical imaging)
| 3
|
[
"Pathologically",
"proven",
"recurrent",
"disease",
"or",
"a",
"second",
"primary",
"(",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"head",
"and",
"neck",
",",
"nasopharyngeal",
"cancer",
",",
"salivary",
"gland",
"cancer",
",",
"or",
"thyroid",
"cancer",
")",
"within",
"the",
"head",
"and",
"neck",
"region",
",",
"deemed",
"to",
"be",
"unresectable",
"or",
"resected",
"with",
"gross",
"residual",
"disease",
"remaining",
"(",
"determined",
"by",
"either",
"operative/pathology",
"report",
"or",
"post-surgical",
"imaging",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
3,
3,
0,
3,
3,
0,
3,
3,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02193373
|
8:11:treatment
|
Normal EKG
| 3
|
[
"Normal",
"EKG"
] |
[
0,
1
] |
NCT02268253
|
14:23:treatment,29:41:treatment,43:63:treatment,68:84:treatment,
|
has received treatment with chemotherapy, wide-field radiation, or biologic therapy within 14 days of study entry
| 3
|
[
"has",
"received",
"treatment",
"with",
"chemotherapy",
",",
"wide-field",
"radiation",
",",
"or",
"biologic",
"therapy",
"within",
"14",
"days",
"of",
"study",
"entry"
] |
[
0,
0,
1,
0,
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02501096
|
1:27:treatment,,104:125:treatment,,154:179:treatment
|
Prior anticancer treatment within 28 days (or 5 times the half-life time, whichever is shorter) or any investigational agent within 30 days prior to the first dose of study drugs
| 3
|
[
"Prior",
"anticancer",
"treatment",
"within",
"28",
"days",
"(",
"or",
"5",
"times",
"the",
"half-life",
"time",
",",
"whichever",
"is",
"shorter",
")",
"or",
"any",
"investigational",
"agent",
"within",
"30",
"days",
"prior",
"to",
"the",
"first",
"dose",
"of",
"study",
"drugs"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT02422641
|
55:80:cancer,84:98:treatment,106:118:treatment,141:157:cancer
|
Cytologic or unequivocal radiographic confirmation of leptomeningeal metastasis by dural puncture and/or neuroimaging with or without known brain metastasis
| 3
|
[
"Cytologic",
"or",
"unequivocal",
"radiographic",
"confirmation",
"of",
"leptomeningeal",
"metastasis",
"by",
"dural",
"puncture",
"and/or",
"neuroimaging",
"with",
"or",
"without",
"known",
"brain",
"metastasis"
] |
[
0,
0,
0,
0,
0,
0,
3,
3,
0,
1,
1,
0,
1,
0,
0,
0,
0,
3,
3
] |
NCT02578901
|
47:75:treatment
|
Subjects who are unwilling to accept blood or blood component transfusions
| 3
|
[
"Subjects",
"who",
"are",
"unwilling",
"to",
"accept",
"blood",
"or",
"blood",
"component",
"transfusions"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0
] |
NCT02535936
|
4:38:treatment
|
No Selective Dorsal Rhizotomy surgery
| 3
|
[
"No",
"Selective",
"Dorsal",
"Rhizotomy",
"surgery"
] |
[
0,
1,
1,
1,
1
] |
NCT03072238
|
,32:42:treatment,74:107:treatment,121:152:treatment,164:179:chronic_disease,187:205:chronic_disease
|
Need of more than 10 mg/day of prednisone or an equivalent dose of other anti-inflammatory corticosteroids as a current systemic corticosteroid therapy to treat a chronic disease (e.g., rheumatic disorder)
| 3
|
[
"Need",
"of",
"more",
"than",
"10",
"mg/day",
"of",
"prednisone",
"or",
"an",
"equivalent",
"dose",
"of",
"other",
"anti-inflammatory",
"corticosteroids",
"as",
"a",
"current",
"systemic",
"corticosteroid",
"therapy",
"to",
"treat",
"a",
"chronic",
"disease",
"(",
"e.g.",
",",
"rheumatic",
"disorder",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0
] |
NCT02162511
|
17:62:treatment,75:84:treatment,100:143:treatment,149:182:treatment,198:217:treatment
|
Able to receive granulocyte colony-stimulating factor (G-CSF) and undergo apheresis either through placement of catheters in antecubital veins or a temporary central venous catheter OR agrees on a bone marrow harvest
| 3
|
[
"Able",
"to",
"receive",
"granulocyte",
"colony-stimulating",
"factor",
"(",
"G-CSF",
")",
"and",
"undergo",
"apheresis",
"either",
"through",
"placement",
"of",
"catheters",
"in",
"antecubital",
"veins",
"or",
"a",
"temporary",
"central",
"venous",
"catheter",
"OR",
"agrees",
"on",
"a",
"bone",
"marrow",
"harvest"
] |
[
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
1
] |
NCT02204098
|
1:17:chronic_disease,
|
Syncopal episode within 12 months of screening
| 3
|
[
"Syncopal",
"episode",
"within",
"12",
"months",
"of",
"screening"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT03165227
|
1:23:chronic_disease,43:60:treatment,,,111:126:chronic_disease
|
coronary heart disease not compensated by medical treatment (supine pulse rate >70 beats per minute, existing angina pectoris)
| 3
|
[
"coronary",
"heart",
"disease",
"not",
"compensated",
"by",
"medical",
"treatment",
"(",
"supine",
"pulse",
"rate",
">",
"70",
"beats",
"per",
"minute",
",",
"existing",
"angina",
"pectoris",
")"
] |
[
2,
2,
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT02549937
|
1:26:chronic_disease,,,,
|
Uncontrolled hypertension, defined as: systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg
| 3
|
[
"Uncontrolled",
"hypertension",
",",
"defined",
"as",
":",
"systolic",
"blood",
"pressure",
"≥",
"140",
"mmHg",
"and/or",
"diastolic",
"blood",
"pressure",
"≥",
"90",
"mmHg"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02483910
|
31:49:chronic_disease,53:74:chronic_disease,115:124:treatment,132:150:chronic_disease,152:168:chronic_disease,190:200:chronic_disease,209:228:chronic_disease
|
Presence of a current serious behavioral problem or psychiatric condition in the child that would require another treatment (e.g., psychotic disorder, major depression, moderate or greater aggression, severe disruptive behavior) based on all available information collected at screening
| 3
|
[
"Presence",
"of",
"a",
"current",
"serious",
"behavioral",
"problem",
"or",
"psychiatric",
"condition",
"in",
"the",
"child",
"that",
"would",
"require",
"another",
"treatment",
"(",
"e.g.",
",",
"psychotic",
"disorder",
",",
"major",
"depression",
",",
"moderate",
"or",
"greater",
"aggression",
",",
"severe",
"disruptive",
"behavior",
")",
"based",
"on",
"all",
"available",
"information",
"collected",
"at",
"screening"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02988895
|
30:46:treatment
|
Patient unsuitable for IV or local anesthesia
| 3
|
[
"Patient",
"unsuitable",
"for",
"IV",
"or",
"local",
"anesthesia"
] |
[
0,
0,
0,
0,
0,
1,
1
] |
NCT02332928
|
16:32:treatment,34:43:treatment,48:56:treatment
|
Current use of American ginseng, remelteon, or warfarin
| 3
|
[
"Current",
"use",
"of",
"American",
"ginseng",
",",
"remelteon",
",",
"or",
"warfarin"
] |
[
0,
0,
0,
1,
1,
0,
1,
0,
0,
1
] |
NCT02393794
|
32:40:treatment,50:58:treatment,67:81:treatment,86:95:treatment
|
Subject is currently receiving warfarin or other coumarin derived anti-coagulant for treatment
| 3
|
[
"Subject",
"is",
"currently",
"receiving",
"warfarin",
"or",
"other",
"coumarin",
"derived",
"anti-coagulant",
"for",
"treatment"
] |
[
0,
0,
0,
0,
1,
0,
0,
1,
0,
1,
0,
1
] |
NCT02393690
|
35:57:treatment
|
Not willing to discontinue use of supplemental vitamin E
| 3
|
[
"Not",
"willing",
"to",
"discontinue",
"use",
"of",
"supplemental",
"vitamin",
"E"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01895777
|
,,78:112:treatment
|
initially treated (minimum of 5 to 7 days, but not longer than 21 days) with parenteral anticoagulation therapy
| 3
|
[
"initially",
"treated",
"(",
"minimum",
"of",
"5",
"to",
"7",
"days",
",",
"but",
"not",
"longer",
"than",
"21",
"days",
")",
"with",
"parenteral",
"anticoagulation",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02553161
|
1:33:chronic_disease
|
pervasive developmental disorder
| 3
|
[
"pervasive",
"developmental",
"disorder"
] |
[
2,
2,
2
] |
NCT02389517
|
24:43:treatment,56:87:treatment,91:106:treatment,123:130:cancer,166:174:treatment,176:188:treatment
|
Patients who completed induction treatment followed by autologous stem cell transplant as initial therapy for symptomatic myeloma as per IMWG criteria and initiated Revlimid (lenalidomide) maintenance
| 3
|
[
"Patients",
"who",
"completed",
"induction",
"treatment",
"followed",
"by",
"autologous",
"stem",
"cell",
"transplant",
"as",
"initial",
"therapy",
"for",
"symptomatic",
"myeloma",
"as",
"per",
"IMWG",
"criteria",
"and",
"initiated",
"Revlimid",
"(",
"lenalidomide",
")",
"maintenance"
] |
[
0,
0,
0,
1,
1,
0,
0,
1,
1,
1,
1,
0,
1,
1,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0
] |
NCT02592707
|
15:27:treatment,
|
Any extensive radiotherapy ≤ 3 months before enrolment
| 3
|
[
"Any",
"extensive",
"radiotherapy",
"≤",
"3",
"months",
"before",
"enrolment"
] |
[
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02044120
|
39:78:treatment,,165:190:chronic_disease,195:222:treatment,
|
Patients who have received allogeneic hematopoietic stem cell transplantation will be eligible 6 months after the procedure provided there is no evidence of active graft-versus-host disease and immunosuppressive treatment has been discontinued for at least 30 days
| 3
|
[
"Patients",
"who",
"have",
"received",
"allogeneic",
"hematopoietic",
"stem",
"cell",
"transplantation",
"will",
"be",
"eligible",
"6",
"months",
"after",
"the",
"procedure",
"provided",
"there",
"is",
"no",
"evidence",
"of",
"active",
"graft-versus-host",
"disease",
"and",
"immunosuppressive",
"treatment",
"has",
"been",
"discontinued",
"for",
"at",
"least",
"30",
"days"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02162420
|
1:22:chronic_disease
|
refractory cytopenias
| 3
|
[
"refractory",
"cytopenias"
] |
[
2,
2
] |
NCT02167009
|
12:20:cancer,24:38:cancer,32:38:cancer
|
History of prostate or bladder cancer, or currently being evaluated for cancer
| 3
|
[
"History",
"of",
"prostate",
"or",
"bladder",
"cancer",
",",
"or",
"currently",
"being",
"evaluated",
"for",
"cancer"
] |
[
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02556606
|
,34:47:chronic_disease,,
|
Age-related cognitive decline or mild dementia suggested by a score of < 25 on the Mini-Mental State Examination (MMSE) at Screening
| 3
|
[
"Age-related",
"cognitive",
"decline",
"or",
"mild",
"dementia",
"suggested",
"by",
"a",
"score",
"of",
"<",
"25",
"on",
"the",
"Mini-Mental",
"State",
"Examination",
"(",
"MMSE",
")",
"at",
"Screening"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01730937
|
16:26:cancer,35:63:cancer,68:91:cancer,
|
Prior invasive malignancy (except non-melanomatous skin cancer and T1 renal cell carcinoma) unless disease free for a minimum of 2 years
| 3
|
[
"Prior",
"invasive",
"malignancy",
"(",
"except",
"non-melanomatous",
"skin",
"cancer",
"and",
"T1",
"renal",
"cell",
"carcinoma",
")",
"unless",
"disease",
"free",
"for",
"a",
"minimum",
"of",
"2",
"years"
] |
[
0,
0,
3,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02250157
|
,,62:80:treatment,89:101:treatment,109:131:treatment,,,
|
Woman must be postmenopausal (> 12 months without menses) or surgically sterile (ie, by hysterectomy and/or bilateral oophorectomy) or must be using effective contraception (ie, oral contraceptives, intrauterine device, double barrier method of condom and spermicide) and agree to continue use of contraception for 30 days after their last dose of IP
| 3
|
[
"Woman",
"must",
"be",
"postmenopausal",
"(",
">",
"12",
"months",
"without",
"menses",
")",
"or",
"surgically",
"sterile",
"(",
"ie",
",",
"by",
"hysterectomy",
"and/or",
"bilateral",
"oophorectomy",
")",
"or",
"must",
"be",
"using",
"effective",
"contraception",
"(",
"ie",
",",
"oral",
"contraceptives",
",",
"intrauterine",
"device",
",",
"double",
"barrier",
"method",
"of",
"condom",
"and",
"spermicide",
")",
"and",
"agree",
"to",
"continue",
"use",
"of",
"contraception",
"for",
"30",
"days",
"after",
"their",
"last",
"dose",
"of",
"IP"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02016781
|
18:53:treatment
|
No intent to use myeloablative conditioning regimens
| 3
|
[
"No",
"intent",
"to",
"use",
"myeloablative",
"conditioning",
"regimens"
] |
[
0,
0,
0,
0,
1,
1,
1
] |
NCT02988895
|
13:28:treatment
|
A change in anti-VEGF agent in the previous two administrations
| 3
|
[
"A",
"change",
"in",
"anti-VEGF",
"agent",
"in",
"the",
"previous",
"two",
"administrations"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02027948
|
,,108:125:treatment
|
Patients can be KPS ≥60, as long as primary provider feels that patient is candidate for combined modality chemoradiotherapy
| 3
|
[
"Patients",
"can",
"be",
"KPS",
"≥60",
",",
"as",
"long",
"as",
"primary",
"provider",
"feels",
"that",
"patient",
"is",
"candidate",
"for",
"combined",
"modality",
"chemoradiotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02620449
|
18:23:allergy_name
|
Allergies to any foods in the standardized diets
| 3
|
[
"Allergies",
"to",
"any",
"foods",
"in",
"the",
"standardized",
"diets"
] |
[
0,
0,
0,
4,
0,
0,
0,
0
] |
NCT01896999
|
17:26:treatment,27:38:treatment,83:99:treatment
|
patients in the nivolumab/brentuximab cohorts ONLY (D, E, F, Y) may have received prior ipilimumab
| 3
|
[
"patients",
"in",
"the",
"nivolumab/brentuximab",
"cohorts",
"ONLY",
"(",
"D",
",",
"E",
",",
"F",
",",
"Y",
")",
"may",
"have",
"received",
"prior",
"ipilimumab"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02982226
|
1:24:chronic_disease
|
Plantar Fascial rupture
| 3
|
[
"Plantar",
"Fascial",
"rupture"
] |
[
2,
2,
2
] |
NCT02942095
|
12:37:chronic_disease,39:78:chronic_disease,89:123:chronic_disease
|
Ongoing or active systemic infection, active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive
| 3
|
[
"Ongoing",
"or",
"active",
"systemic",
"infection",
",",
"active",
"hepatitis",
"B",
"or",
"C",
"virus",
"infection",
",",
"or",
"known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"positive"
] |
[
0,
0,
2,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT03042689
|
20:47:cancer
|
curatively treated non-melanoma skin carcinoma
| 3
|
[
"curatively",
"treated",
"non-melanoma",
"skin",
"carcinoma"
] |
[
0,
0,
3,
3,
3
] |
NCT02908906
|
1:15:cancer,
|
archival tumor blocks within 5 years of collection
| 3
|
[
"archival",
"tumor",
"blocks",
"within",
"5",
"years",
"of",
"collection"
] |
[
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT02132598
|
1:31:chronic_disease,,,
|
Congestive heart failure (CHF): New York Heart Association (NYHA) Class III (moderate) or Class IV (severe) at the time of screening
| 3
|
[
"Congestive",
"heart",
"failure",
"(",
"CHF",
")",
":",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"Class",
"III",
"(",
"moderate",
")",
"or",
"Class",
"IV",
"(",
"severe",
")",
"at",
"the",
"time",
"of",
"screening"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02414672
|
19:31:cancer,51:55:cancer,,83:92:treatment
|
Patient has stage 3B or 4 NSLC or extensive stage SCLC and is within one month of treatment initiation
| 3
|
[
"Patient",
"has",
"stage",
"3B",
"or",
"4",
"NSLC",
"or",
"extensive",
"stage",
"SCLC",
"and",
"is",
"within",
"one",
"month",
"of",
"treatment",
"initiation"
] |
[
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02128100
|
1:43:chronic_disease
|
Acquired Immune Deficiency Syndrome (AIDS) based on CDC criteria
| 3
|
[
"Acquired",
"Immune",
"Deficiency",
"Syndrome",
"(",
"AIDS",
")",
"based",
"on",
"CDC",
"criteria"
] |
[
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02169830
|
14:36:chronic_disease
|
Patient with traumatic brain injury
| 3
|
[
"Patient",
"with",
"traumatic",
"brain",
"injury"
] |
[
0,
0,
2,
2,
2
] |
NCT02532621
|
21:36:chronic_disease,40:57:chronic_disease,70:79:treatment,85:93:treatment,97:104:treatment
|
Subject has a known hypercoagulable or bleeding disorder or requires treatment with warfarin or heparin
| 3
|
[
"Subject",
"has",
"a",
"known",
"hypercoagulable",
"or",
"bleeding",
"disorder",
"or",
"requires",
"treatment",
"with",
"warfarin",
"or",
"heparin"
] |
[
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
1,
0,
1,
0,
1
] |
NCT02234934
|
50:59:chronic_disease,104:119:treatment,128:148:treatment
|
At least one prior, ongoing or refractory severe infection and/or inflammatory complications requiring hospitalization despite conventional therapy
| 3
|
[
"At",
"least",
"one",
"prior",
",",
"ongoing",
"or",
"refractory",
"severe",
"infection",
"and/or",
"inflammatory",
"complications",
"requiring",
"hospitalization",
"despite",
"conventional",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
1,
0,
1,
1
] |
NCT01389024
|
17:20:treatment
|
Failure to pass MRI screening checklist
| 3
|
[
"Failure",
"to",
"pass",
"MRI",
"screening",
"checklist"
] |
[
0,
0,
0,
1,
0,
0
] |
NCT02471430
|
9:22:chronic_disease
|
chronic liver disease
| 3
|
[
"chronic",
"liver",
"disease"
] |
[
0,
2,
2
] |
NCT03097588
|
28:58:chronic_disease
|
Subjects with a history of anxiety-induced (anticipatory) nausea and vomiting
| 3
|
[
"Subjects",
"with",
"a",
"history",
"of",
"anxiety-induced",
"(",
"anticipatory",
")",
"nausea",
"and",
"vomiting"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02837510
|
1:16:chronic_disease
|
Color blindness
| 3
|
[
"Color",
"blindness"
] |
[
2,
2
] |
NCT01525901
|
1:20:chronic_disease
|
renal insufficiency
| 3
|
[
"renal",
"insufficiency"
] |
[
2,
2
] |
NCT01756040
|
13:27:chronic_disease,34:54:chronic_disease,56:76:chronic_disease,,,104:128:chronic_disease
|
Significant GI dysfunction (e.g. heme-positive stools, abdominal distension (girth >2 cm baseline), or bilious emesis/aspirates
| 3
|
[
"Significant",
"GI",
"dysfunction",
"(",
"e.g",
".",
"heme-positive",
"stools",
",",
"abdominal",
"distension",
"(",
"girth",
">",
"2",
"cm",
"baseline",
")",
",",
"or",
"bilious",
"emesis/aspirates"
] |
[
0,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02997709
|
13:32:treatment
|
No previous pelvic radiotherapy
| 3
|
[
"No",
"previous",
"pelvic",
"radiotherapy"
] |
[
0,
0,
1,
1
] |
NCT02332291
|
19:30:chronic_disease
|
Presence of acute suicidality
| 3
|
[
"Presence",
"of",
"acute",
"suicidality"
] |
[
0,
0,
0,
2
] |
NCT02286843
|
1:4:chronic_disease
|
CNS only disease on recent imaging
| 3
|
[
"CNS",
"only",
"disease",
"on",
"recent",
"imaging"
] |
[
2,
0,
0,
0,
0,
0
] |
NCT03137771
|
,49:81:cancer,63:81:cancer,88:115:treatment
|
Patients with more than 3 discrete locations of extra-cranial metastatic disease after first-line systemic therapy requiring more than 3 SBRT plans to cover these distinct metastatic disease entities
| 3
|
[
"Patients",
"with",
"more",
"than",
"3",
"discrete",
"locations",
"of",
"extra-cranial",
"metastatic",
"disease",
"after",
"first-line",
"systemic",
"therapy",
"requiring",
"more",
"than",
"3",
"SBRT",
"plans",
"to",
"cover",
"these",
"distinct",
"metastatic",
"disease",
"entities"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02985554
|
52:71:allergy_name
|
History of severe hypersensitivity reaction to any monoclonal antibody
| 3
|
[
"History",
"of",
"severe",
"hypersensitivity",
"reaction",
"to",
"any",
"monoclonal",
"antibody"
] |
[
0,
0,
0,
0,
0,
0,
0,
4,
4
] |
NCT01945814
|
10:35:treatment,
|
Received donor lymphocyte infusion in last 28 days
| 3
|
[
"Received",
"donor",
"lymphocyte",
"infusion",
"in",
"last",
"28",
"days"
] |
[
0,
1,
1,
1,
0,
0,
0,
0
] |
NCT02442323
|
15:40:cancer
|
Patients with islet cell/neuroendocrine
| 3
|
[
"Patients",
"with",
"islet",
"cell/neuroendocrine"
] |
[
0,
0,
3,
3
] |
NCT02803359
|
12:25:treatment
|
History of Brain Surgery
| 3
|
[
"History",
"of",
"Brain",
"Surgery"
] |
[
0,
0,
1,
1
] |
NCT00737893
|
27:41:chronic_disease
|
The patient has a history liver problems
| 3
|
[
"The",
"patient",
"has",
"a",
"history",
"liver",
"problems"
] |
[
0,
0,
0,
0,
0,
2,
2
] |
NCT02581215
|
11:22:treatment,57:65:treatment,67:74:treatment,,139:175:treatment,177:183:treatment,195:204:treatment,206:214:treatment,229:241:treatment,245:256:treatment
|
Receiving medications that can effect clotting ability: warfarin, aspirin (once-daily aspirin use- maximum dose 325 mg/day is permitted), nonsteroidal anti-inflammatory drugs (NSAIDs, including ibuprofen, naproxen, and others), dipyridamole or clopidogrel, or similar agents
| 3
|
[
"Receiving",
"medications",
"that",
"can",
"effect",
"clotting",
"ability",
":",
"warfarin",
",",
"aspirin",
"(",
"once-daily",
"aspirin",
"use-",
"maximum",
"dose",
"325",
"mg/day",
"is",
"permitted",
")",
",",
"nonsteroidal",
"anti-inflammatory",
"drugs",
"(",
"NSAIDs",
",",
"including",
"ibuprofen",
",",
"naproxen",
",",
"and",
"others",
")",
",",
"dipyridamole",
"or",
"clopidogrel",
",",
"or",
"similar",
"agents"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0
] |
NCT03088033
|
40:63:chronic_disease
|
Known clinically significant untreated carotid artery stenosis likely to require intervention
| 3
|
[
"Known",
"clinically",
"significant",
"untreated",
"carotid",
"artery",
"stenosis",
"likely",
"to",
"require",
"intervention"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.